Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Jul;47(7):953-954.
doi: 10.1007/s00270-024-03774-1. Epub 2024 Jun 10.

Blocking Arteries to Block Obesity

Charles Pirlet  1 , Olivier F Bertrand  2
Affiliations
Editorial

Blocking Arteries to Block Obesity

Charles Pirlet et al. Cardiovasc Intervent Radiol. 2024 Jul.
No abstract available

PubMed Disclaimer

References

    1. Jastreboff AM, Kaplan LM, Frias JP, et al. Triple-hormone-receptor agonist retatrutide for obesity—a phase 2 trial. N Engl J Med. 2023;389:514–26. - DOI - PubMed
    1. Pirlet C, Ruzsa Z, Nemes B, Poirier P, Bertrand OF. Long-term outcomes and weight loss after bariatric embolization of the left gastric artery. J Invasive Cardiol. 2020;32:310–4. - PubMed
    1. Reddy VY, Neuzil P, Musikantow D, et al. Transcatheter bariatric embolotherapy for weight reduction in Obesity. J Am Coll Cardiol. 2020;76:2305–17. - DOI - PubMed
    1. Diana M, Pop R, Beaujeux R, et al. Embolization of arterial gastric supply in obesity (EMBARGO): an endovascular approach in the management of morbid obesity. Proof of the concept in the porcine model. Obes Surg. 2015;25:550–8. - DOI - PubMed
    1. di Giuseppe R, Hansel B, PuyraimondZemmour J, Vilgrain V, Ronot M, Garzelli L. Adding short to left gastric artery embolization for the treatment of obesity safety and effectiveness. Cardiovasc Intervent Radiol. 2024. https://doi.org/10.1007/s00270-024-03702-3 . - DOI - PubMed

Publication types

LinkOut - more resources